Portal de investigação
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study.
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
Citar a publicação
Girerd N,Levy D,Duarte K,Ferreira JP,Ballantyne C,Collier T,Pizard A,Björkman J,Butler J,Clark A,Cleland JG,Delles C,Diez J,González A,Hazebroek M,Ho J,Huby A,Hwang S,Latini R,Mariottoni B,Mebazaa A,Pellicori P,Sattar N,Sever P,Staessen JA,Verdonschot J,Heymans S,Rossignol P,Zannad F. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study. Circ. Heart Fail. 2023. 16. (5):IF:9,700. (1).
